Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02301936 |
|---|---|
| Brief Title: | Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Sickle Cell Disease |
| First Submitted : | November 24, 2014 |
| First Submitted that Met QC Criteria : | November 24, 2014 |
| First Posted : | November 26, 2014 (Estimate) |
| Results First Submitted : | April 18, 2017 |
| Results First Submitted that Met QC Criteria : | April 18, 2017 |
| Results First Posted : | May 25, 2017 |
| Last Update Submitted that Met QC Criteria : | October 19, 2018 |
| Last Update Posted : | November 19, 2018 |